Persistent perturbation of the circadian clock by chronic hepatitis C virus infection following cure with direct-acting antivirals

被引：0
|
作者：
Juhling, Frank [1 ,2 ]
Mukherji, Atish [1 ,2 ]
Mailly, Laurent [1 ,2 ]
Eller, Carla [1 ,2 ]
Ponsolles, Clara [1 ,2 ]
Herzog, Katharina [1 ,2 ]
Hamdane, Nourdine [1 ,2 ]
Zhuang, Xiaodong [3 ]
Aikata, Hiroshi [4 ]
Imamura, Michio [4 ]
Holmes, Jacinta [5 ]
Wang, Shu-Chi [6 ,7 ]
Yu, Ming-Lung [8 ,9 ,10 ]
Chung, Raymond [11 ,12 ]
Schuster, Catherine [1 ,2 ]
Felli, Emanuele [1 ,2 ,13 ]
Pessaux, Patrick [1 ,2 ,13 ]
McKeating, Jane [3 ]
Chayama, Kazuaki [4 ]
Baumert, Thomas [1 ,2 ,13 ,14 ]
机构：
[1] Univ Strasbourg, Strasbourg, France
[2] Inst Rech Ies Malad Virales & Hepat, Inserm U1110, Strasbourg, France
[3] Univ Oxford, Nuffield Dept Med, Oxford, England
[4] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
[5] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia
[6] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan
[7] Kaohsiung Med Univ, Ctr Canc Res & Liquid Biopsy, Kaohsiung, Taiwan
[8] Kaohsiung Med Univ Hosp, Dept Internal Med & Hepatitis Ctr, Hepatobiliary Div, Kaohsiung, Taiwan
[9] Kaohsiung Med Univ, Coll Med, Hepatitis Res Ctr, Kaohsiung, Taiwan
[10] Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res, Kaohsiung, Taiwan
[11] Massachusetts Gen Hosp, Div Gastroenterol, Liver Ctr, Boston, MA 02114 USA
[12] Harvard Med Sch, Boston, MA 02115 USA
[13] Nouvel Hop Civil, Inst Hosp Univ, Pole Hepatodigestif, Strasbourg, France
[14] Inst Univ France, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-602
引用
收藏
页码：S780 / S780
页数：1
相关论文
共 50 条
  • [21] Can we cure hepatitis B virus with novel direct-acting antivirals?
    Martinez, Maria G.
    Villeret, Francois
    Testoni, Barbara
    Zoulim, Fabien
    LIVER INTERNATIONAL, 2020, 40 : 27 - 34
  • [22] Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals
    Nevola, Riccardo
    Rinaldi, Luca
    Zeni, Letizia
    Sasso, Ferdinando C.
    Pafundi, Pia C.
    Guerrera, Barbara
    Marrone, Aldo
    Giordano, Mauro
    Adinolfi, Luigi E.
    JGH OPEN, 2020, 4 (04): : 713 - 721
  • [23] Direct-acting antivirals for children and adolescents with chronic hepatitis C
    Indolfi, Giuseppe
    Serranti, Daniele
    Resti, Massimo
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (04): : 298 - 304
  • [24] Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 307 - 319
  • [25] Treatment of hepatitis C virus infection: From therapy with interferon to direct-acting antivirals
    Lopera, Laura
    Posada, Carolina
    Montoya-Guzman, Melissa
    Munoz, Daniela
    Navas, Maria-Cristina
    IATREIA, 2023, 36 (01) : 51 - 68
  • [26] Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections
    Torres, Maria Corina Plaz
    Lleo, Ana
    Aghemo, Alessio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 5 - 6
  • [27] Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project
    Coyer, Liza
    Njoya, Oudou
    Njouom, Richard
    Mossus, Tatiana
    Kowo, Mathurin Pierre
    Essomba, Frida
    Boers, Alexander
    Coutinho, Roel
    Ondoa, Pascale
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2020, 25 (09) : 1098 - 1109
  • [28] Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection
    Casey, Julia L.
    Dore, Gregory J.
    Grebely, Jason
    Matthews, Gail V.
    Cherepanov, Vera
    Martinello, Marianne
    Marks, Philippa
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Kaul, Rupert
    MacParland, Sonya A.
    Gehring, Adam J.
    Feld, Jordan J.
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (01) : 64 - 72
  • [29] The Effect on Renal Function Following Treatment with Direct-Acting Antivirals for Hepatitis C Virus (HCV) Infection.
    Polo Lorduy, Benjamin Arturo
    Rodriguez, Sara
    Gonzalez, Emilio
    Fresneda, Diana
    Gonzalez Guirado, Agustina M.
    Calvo, Rocio
    Carlos Porres, Juan
    HEPATOLOGY, 2018, 68 : 395A - 395A
  • [30] BUDGET IMPACT ANALYSIS OF NOVEL DIRECT-ACTING ANTIVIRALS FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN TAIWAN
    Kuo, W. J.
    Lin, C. L.
    Lang, H. C.
    VALUE IN HEALTH, 2019, 22 : S207 - S207
12345